Plenary Session
4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial
June 04, 2022
Continuous vs. Fixed, 3 vs 2, PFS is the primary …
A podcast on medicine, oncology, & health policy.…
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!